About Andrew Dreyfus
Andrew Dreyfus is a director at Alto Neuroscience.
Andrew Dreyfus reports to the SEC as a director of 2 public companies, including Ironwood Pharmaceuticals (IRWD).
Andrew Dreyfus first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Dreyfus in the role, so the role may have started earlier or lasted longer.
II
Ironwood Pharmaceuticals Inc.
Director
2016 – 2025 · Public company (IRWD)
Key Colleagues at Startups
The people Andrew Dreyfus works with at each company, as listed on that company's latest Form D.
Alto Neuroscience, Inc. · Form D, Oct 27, 2025
AS
Adam Savitz
Executive officer
AE
Amit Etkin
Executive officer and director
NS
Nicholas Smith
Chief Financial Officer and Chief Business Officer
GY
Gwill York
Director
HM
Husseini Manji
Director
CC
Christopher Cox
Director
RS
Raymond Sanchez
Director
MH
Michael Hanley
Executive officer